secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001104659-24-048318
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth appoints Suzanne Foster CEO effective May 20; Richard Barasch to step down
--------------------------------------------------------------------------------

- Suzanne Foster, former President of Beckman Coulter Life Sciences (Danaher), named CEO and board member effective May 20, 2024.
- Interim CEO and Chairman Richard Barasch will cease as interim CEO on May 20, remain Chairman until June 30, then resign as director and serve as special advisor.
- CEO employment agreement provides $900,000 base salary, target annual bonus of 120% of base, and inducement RSUs worth $4.9M plus $1M with multi-year vesting.
- CFO Jason Clemens' employment amended to increase severance base salary payments from 12 to 18 months on qualifying termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000110465924048318/0001104659-24-048318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000110465924048318/tm2411833d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-048318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer